KeyScreen™ GI Parasite PCR and Lungworms PCR Panel by Antech
)
1 April 2025
Antech Diagnostics Unveils KeyScreen™ GI parasite and Lungworms PCR panel– A Breakthrough in GI Parasite and Lungworms Detection
[Stand E40 BVA- Live] – Antech Diagnostics UK is proud to introduce KeyScreen™ with GI parasite and Lungworms PCR Panel, an innovative diagnostic advancement that elevates parasite screening to a new level of precision. Combining the proven power of KeyScreen™ GI Parasite PCR with the added detection of Lungworms, this cutting-edge panel delivers faster, more accurate insights to veterinary professionals—ultimately supporting improved patient outcomes and responsible antiparasitic stewardship.
"At Antech, we are committed to advancing veterinary medicine through innovative diagnostic solutions. KeyScreen™ with GI parasites and Lungworms detection represents a significant leap forward in our ability to provide accurate and timely diagnoses, ultimately enhancing the care we can offer to our clients and their patients," said Rachel Pittaway, Director of Lab Operations, Antech Diagnostics UK.
Key Benefits of KeyScreen™ PCR Testing
- Enhanced Accuracy: Delivers unparalleled detection of GI parasites and lungworm for more comprehensive, reliable results.
- Improved Clinical Outcomes: Enables veterinarians to initiate faster, more targeted treatment plans.
- Supports One Health Goals: Designed with anthelmintic resistance monitoring and zoonotic awareness in mind.
Revolutionising GI Parasite Diagnostics
Traditional O&P (ova and parasite) and ELISA methods can be limited by subjective interpretation, sample variability, and lower detection rates. KeyScreen™ transforms this landscape with:
- Comprehensive Pathogen Detection: Including Ancylostoma spp., Toxocara spp., Giardia duodenalis, Cryptosporidium spp., Echinococcus spp., Toxoplasma gondii, and now key lungworm species such as Angiostrongylus vasorum and Aelurostrongylus abstrusus.
- Broad Spectrum Screening: Capable of identifying over 27 parasite species, with species identification and resistance testing against Benzimidazoles (i.e. febantel and fenendazole) in hookworms.
- 2x Infection Detection Rate: Compared to centrifugal faecal flotation.
- Zoonotic Awareness: Assesses the zoonotic potential of Giardia duodenalis, aiding in public health efforts and treatment requirements in pets when no clinical signs are present.
- Semi-quantitative results: Parasitic burden (i.e. high, medium, and low) is provided with the detection results to aid in the treatment efficacy evaluation after timely follow-up.
Built for Veterinary Practice Success
The KeyScreen™ GI Parasite and Lungworms PCR panel supports comprehensive parasite diagnosis and prevention, monitoring, and treatment—reflecting best practices outlined in guidelines from organizations such as CAPC, ESCCAP,and CPEP—all at a price point designed to benefit pets, clients and clinics. As parasitic threats and resistance trends grow, KeyScreen™ parasite PCR and Lungworms PCR testing offers a new first line in diagnostics—empowering practices with the tools needed to stay ahead..
Visit Antech Diagnostics at Stand E40 to learn more and experience the future of veterinary diagnostics.